Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AZTA
Upturn stock ratingUpturn stock rating

Azenta Inc (AZTA)

Upturn stock ratingUpturn stock rating
$30.78
Last Close (24-hour delay)
Profit since last BUY1.22%
upturn advisory
Consider higher Upturn Star rating
BUY since 12 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: AZTA (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

7 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $32.25

1 Year Target Price $32.25

Analysts Price Target For last 52 week
$32.25Target price
Low$23.91
Current$30.78
high$63.58

Analysis of Past Performance

Type Stock
Historic Profit -10.41%
Avg. Invested days 36
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.41B USD
Price to earnings Ratio -
1Y Target Price 32.25
Price to earnings Ratio -
1Y Target Price 32.25
Volume (30-day avg) 7
Beta 1.61
52 Weeks Range 23.91 - 63.58
Updated Date 07/1/2025
52 Weeks Range 23.91 - 63.58
Updated Date 07/1/2025
Dividends yield (FY) -
Basic EPS (TTM) -3.27

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -9.77%
Operating Margin (TTM) -8.77%

Management Effectiveness

Return on Assets (TTM) -1.66%
Return on Equity (TTM) -8.58%

Valuation

Trailing PE -
Forward PE 29.07
Enterprise Value 1133090339
Price to Sales(TTM) 2.11
Enterprise Value 1133090339
Price to Sales(TTM) 2.11
Enterprise Value to Revenue 1.69
Enterprise Value to EBITDA 82.22
Shares Outstanding 45779900
Shares Floating 40102317
Shares Outstanding 45779900
Shares Floating 40102317
Percent Insiders 1.79
Percent Institutions 116.99

Analyst Ratings

Rating 2
Target Price 32.25
Buy 1
Strong Buy 1
Buy 1
Strong Buy 1
Hold 5
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Azenta Inc

stock logo

Company Overview

overview logo History and Background

Azenta, Inc. (formerly Brooks Automation) was founded in 1978. Initially focused on automation solutions for the semiconductor industry, it has since evolved to focus on life sciences, particularly in sample management and genomics services. A significant shift occurred in 2021 when Brooks Automation divested its Automation Solutions Group to Thomas H. Lee Partners and rebranded as Azenta, Inc., solidifying its focus on life sciences.

business area logo Core Business Areas

  • Genomics Services: Offers gene sequencing and gene synthesis. Also, services for cell line engineering and GMP manufacturing. Provides tools for researchers to outsource genomics workflows, thus, decreasing timeline, effort, and cost.
  • Sample Management Solutions: Provides automated ultra-low temperature storage solutions to preserve biological samples in both automated and manual formats. Products can be utilized for sample preparation to downstream analyses. Also provides cloud-based information management solutions.

leadership logo Leadership and Structure

Azenta Inc. is led by CEO Steve Schwartz. The company has a typical corporate structure with departments for finance, operations, marketing, and sales. It is headquartered in Burlington, Massachusetts.

Top Products and Market Share

overview logo Key Offerings

  • Automated Storage Solutions: Provides automated cryogenic and ultra-low temperature storage for biological samples. This is a fragmented market with no single dominant player. Competitors include Thermo Fisher Scientific (TMO) and BioLife Solutions (BLFS). Market share is estimated to be ~20%.
  • Genomics Services (Gene Sequencing & Synthesis): Offers genomics services, including gene sequencing, synthesis, and related services. This market is highly competitive with companies like Illumina (ILMN) and Thermo Fisher Scientific (TMO). Market share is estimated to be ~5-10%.
  • Cell Line Development & Manufacturing: Offers both cell line engineering and GMP manufacturing to support various research and development and other commercial applications. Competitors include Thermo Fisher Scientific (TMO) and Lonza Group (LONN.SW). Market share is estimated to be ~5-10%.

Market Dynamics

industry overview logo Industry Overview

The life sciences industry is growing, driven by increased research and development spending, the rise of personalized medicine, and growing demand for biological sample management and genomic solutions. Key trends include automation, digitalization, and the integration of genomics into clinical practice.

Positioning

Azenta is positioned as a provider of sample management and genomics solutions for the life sciences industry. Its competitive advantage lies in its automated storage solutions and its growing genomics services offerings.

Total Addressable Market (TAM)

The total addressable market (TAM) for sample management and genomics solutions is estimated to be in the billions of dollars. Azenta is focused on capturing a larger share of this market through organic growth and acquisitions.

Upturn SWOT Analysis

Strengths

  • Strong position in automated sample management solutions
  • Growing genomics services business
  • Focus on life sciences market
  • Strong management team

Weaknesses

  • Reliance on life sciences market
  • Small relative to bigger players such as Thermo Fisher Scientific (TMO) and Illumina (ILMN)
  • Lower margins compared to peers.

Opportunities

  • Further expansion into genomics services
  • Acquisitions of complementary businesses
  • Partnerships with pharmaceutical and biotechnology companies
  • Growing demand for biostorage solutions

Threats

  • Competition from larger players
  • Economic downturn
  • Technological advancements that could disrupt the market
  • Regulatory changes affecting the life sciences industry

Competitors and Market Share

competitor logo Key Competitors

  • Thermo Fisher Scientific (TMO)
  • Illumina (ILMN)
  • BioLife Solutions (BLFS)

Competitive Landscape

Azenta faces competition from larger, more established players such as Thermo Fisher Scientific and Illumina. Its advantage lies in its specialization in sample management and its growing genomics services offerings.

Major Acquisitions

Boca Scientific

  • Year: 2021
  • Acquisition Price (USD millions): 41
  • Strategic Rationale: Expand capabilities and reach in the biosample supply chain

Growth Trajectory and Initiatives

Historical Growth: Azenta's growth has been driven by acquisitions and organic growth in its sample management and genomics services businesses.

Future Projections: Analyst estimates suggest continued revenue growth in the high single digits to low double digits.

Recent Initiatives: Recent strategic initiatives include acquisitions of companies in the genomics services space and expansion of its sample management solutions portfolio.

Summary

Azenta is a growing player in the life sciences market, focused on sample management and genomics services. It has a strong position in automated storage solutions and is expanding its genomics offerings. While facing competition from larger companies, Azenta's specialization and strategic acquisitions position it for continued growth. However, Azenta should manage integration risks from the acquisitions.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Website
  • Analyst Reports
  • SEC Filings

Disclaimers:

This analysis is for informational purposes only and should not be considered investment advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Azenta Inc

Exchange NASDAQ
Headquaters Burlington, MA, United States
IPO Launch date 1995-02-02
President, CEO & Director Mr. John P. Marotta
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 3000
Full time employees 3000

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.